$13.54
0.604.64%
Ult. Agg.: Nov 6, 4:00 PM
The average analyst price target for Crescent Biopharma is $29, 114.2% above the current price. Of 6 analysts, 6 rate it Buy. Targets range from $22 to $36. The latest change came on Oct 6, 2026, when HC Wainwright & Co. upgraded Crescent Biopharma from Neutral to Buy with a $36 price target.
Price Target Range — 5 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months